CATEGORY: HEALTHY AGING & LONGEVITY
Picture someone in their late seventies whose steps have shrunk to a shuffle, who’s begun to lean on furniture, and whose family has quietly filed it all under old age. Sometimes that’s not aging at all. In a trial of 99 older adults with a fluid buildup in the brain called normal-pressure hydrocephalus, draining that fluid through an implanted tube raised walking speed by 0.23 meters per second within three months, while a placebo version of the same operation raised it by almost nothing.1 Eight in ten people with a working drain reached a meaningful improvement. Fewer than one in four did without it.
Everyone Got the Surgery. Only Half Got the Drain.
Normal-pressure hydrocephalus means the brain’s fluid-filled chambers slowly enlarge and press on the tissue around them. The classic result is a magnetic, gluey walk, trouble holding urine, and thinking that has gone foggy. It mostly appears after 65, and it’s one of the few dementia-like conditions considered treatable. The standard treatment is a shunt: a thin tube, placed by a neurosurgeon, that carries excess fluid from the brain to the abdomen. Surgeons have implanted these for decades. What nobody had done was test the operation against a convincing placebo, so skeptics could always argue that patients improved because they expected to.
This trial closed that gap with an elegant trick. All 99 participants, recruited at 17 centers in the US, Canada and Sweden after a temporary drainage test suggested they’d respond, received the same operation and the same adjustable valve. A computer then secretly set each valve: open at a normal drainage pressure for half the group, and effectively closed for the other half. Patients, families and the doctors examining them had no way to tell which they’d received. That secrecy is what makes the comparison trustworthy.
Faster Steps, Fewer Falls, and Real Surgical Risks
Three months later, the open-valve group walked 0.23 meters per second faster at top speed. The closed-valve group gained 0.03. In everyday terms that’s the difference between a hesitant shuffle and walking with some purpose again, and it cleared the bar researchers consider clinically meaningful for older adults. Falls told the same story: 25% of the open-valve group fell during those months against 46% of the placebo group. Balance improved too. Thinking and bladder control moved in the right direction but didn’t improve significantly in three months, a question the trial’s longer follow-up is still tracking.
The operation isn’t free of danger, and the trial counted the costs honestly. Bleeding on the brain’s surface occurred in 14% of the open-drain group versus 4% with the closed valve, headaches tied to overdrainage were common, and one participant died of a surgical hemorrhage. Walking trouble in later life also has many likelier causes, from arthritis to Parkinson’s disease, and this condition explains only a fraction of it. The trial says the treatment works for carefully selected people who responded to a drainage test first. It doesn’t say every slow walker has fluid to blame.
Key Takeaways
- In the first placebo-controlled trial of shunt surgery for normal-pressure hydrocephalus, an open drain raised walking speed by 0.23 meters per second in three months; a hidden closed valve raised it by 0.03.
- 80% of people with a working drain reached a meaningful gait improvement, versus 24% with the placebo setting, and fewer of them fell.
- Risks were real: more bleeding around the brain and more overdrainage headaches with the open valve, and one surgical death in the trial.
- Cognitive and bladder symptoms hadn’t significantly improved at three months; the trial follows participants for a year to find out whether they do.
References
- Luciano MG, Williams MA, Hamilton MG, et al. A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus. The New England Journal of Medicine. 2025;393(22):2198–2209. link